ES435500A1 - Un procedimiento para la obtencion de un preparado terapeu- tico solido. - Google Patents

Un procedimiento para la obtencion de un preparado terapeu- tico solido.

Info

Publication number
ES435500A1
ES435500A1 ES435500A ES435500A ES435500A1 ES 435500 A1 ES435500 A1 ES 435500A1 ES 435500 A ES435500 A ES 435500A ES 435500 A ES435500 A ES 435500A ES 435500 A1 ES435500 A1 ES 435500A1
Authority
ES
Spain
Prior art keywords
stomach
active ingredient
therapeutic preparation
remaining
solid therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES435500A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES435500A1 publication Critical patent/ES435500A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES435500A 1974-03-12 1975-03-11 Un procedimiento para la obtencion de un preparado terapeu- tico solido. Expired ES435500A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (OSRAM) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
ES435500A1 true ES435500A1 (es) 1977-02-01

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES435500A Expired ES435500A1 (es) 1974-03-12 1975-03-11 Un procedimiento para la obtencion de un preparado terapeu- tico solido.

Country Status (12)

Country Link
US (1) US3976764A (OSRAM)
JP (1) JPS5512411B2 (OSRAM)
BE (1) BE826498A (OSRAM)
CA (1) CA1054056A (OSRAM)
CH (1) CH604719A5 (OSRAM)
DE (1) DE2510620C2 (OSRAM)
DK (1) DK142802B (OSRAM)
ES (1) ES435500A1 (OSRAM)
FR (1) FR2263744B1 (OSRAM)
GB (1) GB1507521A (OSRAM)
NL (1) NL7502952A (OSRAM)
SE (1) SE409286B (OSRAM)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (OSRAM) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
EP0536277A1 (en) * 1990-06-25 1993-04-14 The Du Pont Merck Pharmaceutical Company Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (OSRAM) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP1063973B1 (en) 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
BRPI0407438A (pt) * 2003-02-21 2006-02-07 Lek Pharmaceuticals Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
JP2007510654A (ja) * 2003-11-04 2007-04-26 スパーナス ファーマシューティカルズ インコーポレイテッド 分極した酸素原子を有するポリマーを含むマトリクスからの正に荷電した薬理学的活性分子の徐放
RU2420268C2 (ru) * 2006-09-04 2011-06-10 Панацея Биотек Лимитед Способ программируемой плавучей доставки
WO2010020098A1 (zh) * 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出系统及其制备方法和用途
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2462022B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
CA2767143A1 (en) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Tablet having hollow structure
AU2011275881B2 (en) 2010-07-05 2014-11-06 Jagotec Ag Dosage form
MX2014000517A (es) * 2011-07-14 2014-07-24 Apet Holding B V Composiciones de nicotinamida y el uso terapeutico de las mismas.
WO2013054285A1 (en) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
EP2872140A1 (en) * 2012-07-16 2015-05-20 APeT Holding B.V. Gastro-retentive drug delivery system
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
PL3725357T3 (pl) 2014-06-11 2025-03-03 Massachusetts Institute Of Technology Konstrukcje służące do zmiany przebywania i powiązane sposoby
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3288604B1 (en) 2015-05-01 2021-11-17 Massachusetts Institute of Technology Triggerable shape memory induction devices
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
JP7030052B2 (ja) 2015-12-08 2022-03-04 リンドラ セラピューティクス， インコーポレイティド 胃滞留システムのための幾何学的構成
AU2017235598A1 (en) * 2016-03-18 2018-08-09 Grünenthal GmbH Floating pharmaceutical dosage form
CN119925721A (zh) 2016-05-27 2025-05-06 林德拉治疗公司 用于胃驻留系统的材料结构
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
WO2018064630A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
EP3634382A4 (en) 2017-06-09 2021-07-07 Lyndra Therapeutics, Inc. STOMACHING SYSTEMS WITH RELEASE RATE MODULATING FILMS
US20220409490A1 (en) * 2020-03-02 2022-12-29 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release
ES2955784T3 (es) * 2020-10-14 2023-12-07 Hannes Bichsel Granos biogranulados espumados
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
DE2510620C2 (de) 1984-01-05
DK97875A (OSRAM) 1975-09-13
BE826498A (fr) 1975-06-30
JPS50121418A (OSRAM) 1975-09-23
US3976764A (en) 1976-08-24
SE7502725L (OSRAM) 1975-09-15
GB1507521A (en) 1978-04-19
CH604719A5 (OSRAM) 1978-09-15
SE409286B (sv) 1979-08-13
CA1054056A (en) 1979-05-08
JPS5512411B2 (OSRAM) 1980-04-02
NL7502952A (nl) 1975-09-16
DK142802C (OSRAM) 1981-09-21
FR2263744B1 (OSRAM) 1978-11-24
DE2510620A1 (de) 1975-09-18
DK142802B (da) 1981-02-02
FR2263744A1 (OSRAM) 1975-10-10

Similar Documents

Publication Publication Date Title
ES435500A1 (es) Un procedimiento para la obtencion de un preparado terapeu- tico solido.
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
PT77621A (en) Process for the preparation of liofilized pharmaceutical compo-sitions containing aminocaproic acid
DE2964311D1 (en) An analgesic effervescent powder and process for its preparation
CA984709A (en) Apparatuses for disintegration of straw and similar material
CA997677A (en) Layered bolus for animal husbandry providing for immediate and sustained release of medicament
JPS5572117A (en) Analgesic tablet and its manufacture
ZA714795B (en) Flowable pancreatin preparation of low germ content,and a process for its manufacture
AU4368972A (en) Improvements relating to in vitro determination of active substance in a body
GB934089A (en) Improvements in or relating to sustained release medicaments
JPS5442380A (en) Regenerative capsule
GB630439A (en) Improvements in or relating to pharmaceutical preparations
CH611132A5 (en) Preparation for the controlled release of an effective amount of a biologically active material to the environment, and use of this preparation
GB862376A (en) Sustained release pharmaceutical tablet
SE7407561L (OSRAM)
JPS5513252A (en) Preventive and remedy for swine dysentry
JPS526660A (en) Production of lactulose-including powders for livestock feed
CA964749A (en) Controlled feeding of powdered material
JPS526661A (en) Production of lactulose including powders for livestock feed
JPS5678071A (en) Positive plate for lead acid battery
JPS52130905A (en) Medicinal composition
KR790000108B1 (en) Method for preparation of collapsible gelatine medical capsules
JPS646084A (en) Latent heat-type heat storage material
JPS5350319A (en) Drug discharging means of medical capsule
JPS56127312A (en) Drug for remedy of hepatic disease and recovery from fatigue